David Song, PM of the Cardiovascular and Metabolic ETF for Tema ETFs, was recently interviewed by Benzinga.
Tema is an active investment adviser focused on differentiated strategies managed by experienced investment professionals offered through ETFs and SMAs. Tema primarily focuses on “thematic” investing, providing funds focused on a particular view of the market and society.
The company just launched HRTS focused on companies that are critical in the fight against cardiovascular and metabolic disease, a growing issue the world over.
